chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cold like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced NASOPHARYNGITIS (cold like symptoms). At the time of the report, NASOPHARYNGITIS (cold like symptoms) outcome was unknown. Not Provided          Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.
I developed a rash ( almost the size of a credit card)  Wednesday morning at the site of injection. The rash has since increased in size, but not by much. It still itches, but I have not itched it. It's not a terrible itch, but annoying. No other symptoms noted at this time.
On 2/10/21 started with itching On 2/11/21 itching, burning sensation of skin on entire body Red pin start onpointtype rash on right and left buttocks, hips extending up to breasts rash flat not raised Called primary doctor To take Benadryl 25Mg three times a day until rash gone. On 2/12/21 rah turned into red raised rash to right and left hips groin abdomen breasts extending down legs and up to and around neck itching and burning sensation continues rash much worse No difficulty breathing Went to doctor Rash on back and arms looks like a sunburn to start  Hydroxyzine three times a day
Patient became extremely dizzy after receiving the vaccine. He passed out and hit the floor. Patient was going to go to the hospital.
Starting 01/30/2022, I became extremely nauseous and developed a severe headache. I ended up getting sick and continued feeling poorly. On Tuesday (02/01/2022), I had a telehealth visit with my doctor, who told me to get a COVID-19 test. I got tested and it was positive for COVID-19. I received antibiotics and a steroid from my doctor, and I was given a referral for the monoclonal antibodies; however, due to the limited availability in my area, I was ineligible to get it. I started feeling some better around 02/12/2022 and I have been slowly feeling better since.
rash; arm was swollen; hot; arm was red; arm was itchy; hurt; didn't feel good; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), MALAISE (didn't feel good), VACCINATION SITE SWELLING (arm was swollen), FEELING HOT (hot) and VACCINATION SITE ERYTHEMA (arm was red) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 13-Feb-2021, the patient experienced MALAISE (didn't feel good). On 14-Feb-2021, the patient experienced VACCINATION SITE SWELLING (arm was swollen), FEELING HOT (hot), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE PRURITUS (arm was itchy) and PAIN (hurt). On 15-Feb-2021, the patient experienced RASH (rash). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), MALAISE (didn't feel good), VACCINATION SITE SWELLING (arm was swollen), FEELING HOT (hot), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE PRURITUS (arm was itchy), PAIN (hurt) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  The patient said via phone call that, patient got the 2nd dose of moderna vaccine and didn't remember being too sick. Patient was remembers only having adverse reactions after the 1st dose as they showed up 10 days after the shot.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Significant FU/ TCR information was reported and was added in narrative supplement section.
I was unable to sleep all night waking up every 5 minutes do to body chills/heat waves. Body aches and head aches, fever peaked on Saturday 23rd to 103 but body temperature maxed at 106.  I was battling these symptoms all day saturday and sunday (partial) I was unable to eat much due to the side effects. I also threw up.
Same night as shots she spikes 104 fever. She was sensitive to light and sound. She was dry heaving. She began to have a migraine headache. She had tingling in her foot then leg and then both went numb. This was a Friday night. Clinic and urgent care were closed. I called nurses hotline. Was told to alternate TYLENOL and MOTRIN for fever. I told them she had shots that day and was told this is normal if her fever gets worse or symptoms gets worse bring her into ER and to follow up with PCM when the clinic opens on that Monday. We cold compressed and pushed fluids as much as we could. Her fever broke later the next morning. She laid in bed all day the next day and said she couldn't move her foot or leg. Sunday she was able to feel her foot and leg and Monday was able to walk. We called her PCM Monday and told her what happened after visiting immunization clinic. She recommended that we did not continue with the HPV series.
cold sweats, fever of 100.9 at highest,  knot at injection site,, soreness, redness, pain, swelling
A report has been received from a Health Professional concerning a 12 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 10-Oct-2014. Patient received two FLUMIST quadrivalent does in 8 days which started on 10-Oct-2014. The outcome of the event of patient received two FLUMIST quadrivalent doses in 68 days is unkonwn. The report was considered to be non-serious.
My heart rate has been between 110 & 120 bpm since I woke up 4/8. I recieved my second dose of the Pfizer vaccine around 1:45p on 4/7.
Red indurated soft tissue swelling in right upper lateral arm noted after immunization. Area of 2cmx3cm just inferior to injection site. Not tender.
About 1/2 hr after 2nd varicella injection she developed bil conjunctival redness and itchiness. Responded to IM Benadryl. No skin, no cardio resp reactions.
pt ex red, swollen, sore arm, blotchy in color, lump under inject site, chills, h/a, myalgia and nausea.
Fever lasting approximately 48hrs without fever-reducing medication, muscle aches lasting approximately 8 hours, migraine lasting approximately 24 hours
Swelling and rash to left deltoid. Noticed rash/swelling 4 hrs after receiving vaccine. Mom describes rash as "hives" - area the size of her fist.
first day i woke-up with a stiff neck, the next day it got worse,then a stiff and sore back,stiff and painful joints,chills, body aches,headaches,tiredness,severe pain.dizziness. the only relief was when i used an ace bandage on my wrist that was hurting. the doctor's nurse said that i had probably picked up a cold or a bug and offered no suggestion for relief. time has brought relief to the most severe pain, but it has not completely left as of now.
Occurred while driving. Difficulty keeping car on road while driving lane. Eventually ran off road. Unable to talk or move right arm but otherwise uninjured in crash. Ambulance called by motorist following my vehicle and taken immediately to hospital emergency room. Unable to speak to nurses/doctor at ER. Unable to remember cell phone access code. Recall making noises but not speaking. ER staff contacted neurologist, and were told to administer Alteplase 100 mg SOLR (In 63 and 30 doses) and send by ambulance to hospital for follow-up treatment. In ambulance en route, I began to be able to speak about 1 hour into 2-hour trip and was able to access my cell phone. Able to respond very normally to hospital personnel at hospital upon arrival there. I have been subscribed to V-Safe since my initial Pfizer Injections (1 & 2) but the form doesn't allow information about results from respondent about conditions or reactions. Birthdate on form should be: XX/XX/XXXX (not 9th.... number changes when I moved on to the next item). Health department clinic where Pfizer booster ws given: 1st dose was administered 1/15/21 (FL3249 5/21); second dose was administered 2/5/21 (EM9810). Final booster in this series was the one administered 10/14/21. My personal physician is a DO. She and I have discussed the unusual nature of my having a stroke since I don't have any of the usual illnesses/conditions, am not a smoker and maintain a healthy lifestyle. All hospital test records and reports go to her for any hospitalizations or medical visits.  Please find a enclosed copy of my VAERS Adverse Reaction form related to a seizure I experienced in 2021, 10 days after receiving a Pfizer COVID booster at a local health department vaccination session. I have tried to send this document on-line but apparently have a problems/conflict with the form and my PDF/Adobe applications. Should you have any questions about the form, please contact me or any of the medical personnel listed in the report. I do not believe this seizure incident has been previously reported since none of the hospital involved were aware of the COVID vaccination and its proximity to the seizure. Thank you for your work on behalf of COVID information gathering and sharing! P.S. I did not mention in the form that I have not had COVID since its inception.
Tinnitus, ringing in the ear, feeling clogged, since waking up the day after the vaccine; Soreness in the arm, and other muscles starting the evening of the vaccine.
Nausea, feeling tired, dizzy, headache within 15 min. Rested and drank water.
kept getting bronchitis; kept getting respiratory issue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BRONCHITIS (non-serious), outcome "unknown", described as "kept getting bronchitis"; RESPIRATORY DISORDER (non-serious), outcome "unknown", described as "kept getting respiratory issue".  Additional information: The reporter stated that one of her son was vaccinated and one son was not vaccinated. Her concern was the son that was vaccinated kept getting bronchitis over the other one who was not vaccinated. She asked why her son was who was vaccinated was the one getting sick all the time and other one was not. The reporter stated that his son (patient) was really healthy, he was a teen, he was an athlete and ever since he has got the shot he kept getting respiratory issue. The reporter was concerned if it was new because now the studies were coming out on TV and she read on the website that the vaccine does work but he was getting sick. The reporter asked why he was sick all the time now.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
As soon as after the vaccination, patient claimed that he was having headache and "weird" taste in mouth. Patient instructed to stay for observation. In about 10 minutes, patient said the headache went away but he still felt there was some unusual taste in his mouth. In 45 minutes, patient stated he is doing fine with the "weird" taste subsiding and left. Instructed patient to seek help if he any symptoms returns or worsens. Called and followed up with patient and spoke to him 10/3/18 via phone and he stated all symptoms went away with no recurrence.
After my shot, I got my menstrual cycle and it has been abnormally  and excessively heavy requiring a tampon and pad which have to be changed every 2 hours.  Excessive blood clots throughout this whole time and has not lightened up at all.  This is not normal and have never experienced it like this.
Swollen lymph nodes under arm and neck, body aches and headache X4 days
106 temp for 10 days lethargic not sure of the date that the vaccination was given just found out the Dr did not verify it was a vaccination that caused it so wanted to report it but temp happened very quickly.
FLU-LIKE SYMPTOMS; MIGRAINES; PAIN IN LOWER LEFT ABDOMEN; This spontaneous report received from a patient concerned a 40 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: smoker. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811 and expiry: 20-MAR-2022) dose was not reported, administered on 30-OCT-2021 for prophylactic vaccination. No concomitant medications were reported.  On 30-OCT-2021, the patient experienced flu-like symptoms. On 30-OCT-2021, the patient experienced migraines. On 30-OCT-2021, the patient experienced pain in lower left abdomen. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from flu-like symptoms, migraines, and pain in lower left abdomen. This report was non-serious. This case, from the same reporter is linked to 20211100454.
Severe stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Severe stomach pain) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced ABDOMINAL PAIN UPPER (Severe stomach pain). At the time of the report, ABDOMINAL PAIN UPPER (Severe stomach pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment using Pepto Bismuth was reported and it did nothing.  No concomitant medication were provided.; Sender's Comments: This case concerns a 34-year-old female patient with no medical history, who experienced the unexpected event of Abdominal pain upper. The event of Abdominal pain upper occurred on the same day after receiving the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). The rechallenge was unknown. The information regarding the second dose was not provided.  The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
elevated heart rate; During one event I had to stop the workout to catch my breath; This is a spontaneous report from a contactable consumer (reported for self). A 41-years-old male patient received second dose of BNT162B2 ((COMIRNATY); Formulation: Solution for injection; Lot/Batch number: Not reported), via an unspecified route of administration on an unspecified date in 2021 (at the of 41-years-old) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had earlier received first dose of BNT162B2 ((COMIRNATY); Formulation: Solution for injection; Lot number: EN6204), via an unspecified route of administration in the Left arm on 08Apr2021 12:00 as dose 1, single for COVID-19 immunization and experienced elevated heart rate and Dyspnoea. Prior to vaccination, the patient was not diagnosed with COVID-19. Known allergies and other medical history were none. On an unspecified date in 2021 the patient noticed elevated heart rate when he worked out. The patient's fitness watch tracked 15-20BPM higher than normal (I do the exact same workout almost everyday) for 48 hours after both doses. During one event he had to stop the workout to catch his breath (reported as "During one event I had to stop the workout to catch my breath"). Given some of the reporting of heart inflammation patient thought this would be helpful. Since the vaccination, the patient has not been tested for COVID-19. The lab data includes: Heart rate 15-20BPM higher than normal on an unspecified date in 2021. Patient received no treatment for the adverse events. The events were assessed as non serious. The outcome of events was reported as recovered on unknown date.  Device Date : 25May2021  Follow-up attempts are completed. No further information is expected.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter consumer or other non HCP from product quality group. The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Nov2021 as dose 3 (booster), single (Lot number: Fg3527) at the age of 38 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications.The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Clinical information: Patient had no known allergies. The patient received COVID 19 Treatment paxlovid on 06Jun2022.  Follow-up attempts are completed. No further information is expected.
accidently received Arexvy today on October 20th 2023; Inappropriate age at vaccine administration; This non-serious prospective pregnancy case was reported by a nurse via call center representative and described the occurrence of vaccine exposure during pregnancy in a 37-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 20-OCT-2023, the patient received Arexvy. On 20-OCT-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: accidently received Arexvy today on October 20th 2023). The outcome of the vaccine exposure during pregnancy and inappropriate age at vaccine administration were unknown.   Pregnancy exposure: Gestation time at first exposure (Arexvy): 34 Weeks Pregnancy Exposure (Arexvy): To mother in third trimester Estimated Delivery/Due date: 26-NOV-2023 Pregnancy Outcome: Pregnancy was ongoing   Additional Information: GSK Receipt Date: 20-OCT-2023 Nurse a patient herself is 34 weeks pregnant and accidently received Arexvy today on October 20th 2023 which led to vaccine exposure during pregnancy and inappropriate age at vaccine administration. She wants to know if there is any clinical studies on patient who received Arexvy while pregnant?.The reporter consented to follow up.
Injection site pain & modest swelling - started immediately, continued but improving on day 2, no treatment.  Tiredness - started same day, continued on day 2, no treatment other than napping. Chills & Elevated Temperature of 100.2 starting at 6 PM on day 2, along with generally "feeling unwell," at this time no treatment. (Side effects are mild, but I wanted to record them.)
Initial case report received from a consumer on 22 OCT 2009. A female patient of unknown age was vaccinated i.m. with one dose of FLUVIRIN 2008/2009 (influenza virus vaccine, batch no. unknown) in the 2008-2009 influenza season. Shortly thereafter at an unspecified time, the patient experienced atrial fibrillation. It was not known how long atrial fibrillation lasted. No cardioversion was attempted. At an unspecified time normal rhythm returned. The patient had fully recovered.
No additional AE's; A pharmacist called to report that a dose of PNEUMOVAX 23 that expired on 4/24/2022 was administered to a patient on 8/18/2022.; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reaction or allergies were not reported.   On 18-AUG-2022, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), injection, lot # T028093, expiration date 24-APR-2022 (strength, dose, route of administration, and anatomical location were not provided) for prophylaxis (reported as "use a durected to prevent pnwumococcal infection") (expired product administered). No additional adverse events were reported.
This is a spontaneous report from a non-contactable consumer reporting for herself. This female patient of an unspecified age and ethnicity received PREVNAR 13, via an unspecified route of administration on an unspecified date in 2015 for immunisation.  The patient medical history and concomitant medications were not reported.  The patient previously took influenza vaccine and experienced erythema, diphtheria vaccine one year before pneumococcal 13-val conj vac (dipht crm197 protein) as she was susceptible to having respiratory problems.  The patient experienced arm became brown/the area on arm was like a deck of cards size wise and a rectangular shape on an unspecified date with outcome of unknown. No follow-up attempts are possible. No further information is expected.
Pt is a 75-year-old woman with a history of COPD, chronic alcoholism, hypertension, depression, anxiety, osteoarthritis another orthopedic ailments who presented to the emergency room on 11/20/2021 after family noted several days of confusion.  She had undergone a dental extraction on Wednesday the 17th and was prescribed hydrocodone at that time.  Patient notes that she has been drinking brandy along with the hydrocodone.  She also had developed a cough and some worsening dyspnea on exertion.  Subjective fevers.  She is not on oxygen at baseline with her COPD.  She has been vaccinated for COVID-19.  She had a fall and struck her head sometime prior to admission, she thinks it was over a week ago.  Patient admitted and started on remdesivir.
This spontaneous report as received from a physician refers to a 9 months old patient. The patient was vaccinated with GARDASIL. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced a 9 month old patient received GARDASIL on an unspecified date. No treatment information was reported. The outcome of a 9 month old patient received GARDASIL on an unspecified date is unknown. The relatedness for a 9 month old patient received GARDASIL on an unspecified date in unknown for GARDASIL. No adverse symptoms was reported. No further information was provided.
Patient  is a 10 y.o female here for her second pfizer dose. At about 10:22am patient complained of dizziness and "feeling hot". patient was warm to touch, inital BP was 101/84 and pulse 78bpm.  A cold pack was placed over patients head for about three minutes, patient then complained of weakness in her limbs. Patient was transferred to an available room at the site and was laid supine. patient reported feeling better and repeat BP was 106/78 pulse 83bpm, on further questioning patient admitted to skipping breakfast today. At about 10:30am. patient reported feeling better, EMS arrived on site and patient was taken to the hospital.